First Time Loading...
I

Ilyang Pharmaceutical Co Ltd
KRX:007570

Watchlist Manager
Ilyang Pharmaceutical Co Ltd
KRX:007570
Watchlist
Price: 13 250 KRW -0.15%
Updated: Jun 10, 2024

Ilyang Pharmaceutical Co Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ilyang Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
I
Ilyang Pharmaceutical Co Ltd
KRX:007570
Income from Continuing Operations
-₩204.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Income from Continuing Operations
₩122.6B
CAGR 3-Years
9%
CAGR 5-Years
18%
CAGR 10-Years
4%
SK Biopharmaceuticals Co Ltd
KRX:326030
Income from Continuing Operations
-₩35.4B
CAGR 3-Years
48%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Income from Continuing Operations
₩178.9B
CAGR 3-Years
83%
CAGR 5-Years
35%
CAGR 10-Years
13%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Income from Continuing Operations
-₩3.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Income from Continuing Operations
₩16.5B
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
24%

See Also

What is Ilyang Pharmaceutical Co Ltd's Income from Continuing Operations?
Income from Continuing Operations
-204.4m KRW

Based on the financial report for Mar 31, 2024, Ilyang Pharmaceutical Co Ltd's Income from Continuing Operations amounts to -204.4m KRW.